These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 6323238)
1. Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration. Yonemura Y; Takashima T; Miwa K; Miyazaki I; Yamamoto H; Okamoto H Diabetes; 1984 Apr; 33(4):401-4. PubMed ID: 6323238 [TBL] [Abstract][Full Text] [Related]
2. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Uchigata Y; Yamamoto H; Nagai H; Okamoto H Diabetes; 1983 Apr; 32(4):316-8. PubMed ID: 6299867 [TBL] [Abstract][Full Text] [Related]
3. Induction of islet B-cell regeneration in partially pancreatectomized rats by poly(ADP-ribose) synthetase inhibitors. Yonemura Y; Takashima T; Matsuda Y; Miwa K; Sugiyama K; Miyazaki I; Yamamoto H; Okamoto H Int J Pancreatol; 1988; 3(1):73-82. PubMed ID: 3127497 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes. Masiello P; Cubeddu TL; Frosina G; Bergamini E Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287 [TBL] [Abstract][Full Text] [Related]
5. Effect of poly(ADP-ribose) synthetase inhibitor administration to streptozotocin-induced diabetic rats on insulin and glucagon contents in their pancreas. Shima K; Hirota M; Sato M; Numoto S; Oshima I Diabetes Res Clin Pract; 1987; 3(3):135-42. PubMed ID: 2954803 [TBL] [Abstract][Full Text] [Related]
6. Nicotinamide, a poly (ADP-ribose) synthetase inhibitor, ameliorates B-cell function in partially depancreatized rats. Inoue Y; Tanigawa K; Nakamura S; Kato Y; Tamura K; Nakase A Diabetes Res Clin Pract; 1993; 22(1):19-27. PubMed ID: 8137712 [TBL] [Abstract][Full Text] [Related]
7. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors. Okamoto H; Yamamoto H Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640 [TBL] [Abstract][Full Text] [Related]
8. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. Uchigata Y; Yamamoto H; Kawamura A; Okamoto H J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256 [TBL] [Abstract][Full Text] [Related]
9. Effects of poly (ADP-ribose) synthetase inhibitor on B-cells of a canine pancreas after massive pancreatectomy. Sugiyama K; Yonemura Y; Okamoto H Int J Pancreatol; 1991 Jan; 8(1):85-95. PubMed ID: 1827822 [TBL] [Abstract][Full Text] [Related]
10. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Yamamoto H; Okamoto H Biochem Biophys Res Commun; 1980 Jul; 95(1):474-81. PubMed ID: 6251809 [No Abstract] [Full Text] [Related]
11. Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strand breaks. Yamamoto H; Okamoto H FEBS Lett; 1982 Aug; 145(2):298-302. PubMed ID: 6290270 [No Abstract] [Full Text] [Related]
13. The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells. Okamoto H J Hepatobiliary Pancreat Surg; 1999; 6(3):254-62. PubMed ID: 10526060 [TBL] [Abstract][Full Text] [Related]
14. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro. Masiello P; Novelli M; Fierabracci V; Bergamini E Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620 [TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase. Sandler S; Welsh M; Andersson A Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):392-400. PubMed ID: 6318515 [TBL] [Abstract][Full Text] [Related]
17. Induction of murine teratocarcinoma cell differentiation by suppression of poly(ADP-ribose) synthesis. Ohashi Y; Ueda K; Hayaishi O; Ikai K; Niwa O Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7132-6. PubMed ID: 6095269 [TBL] [Abstract][Full Text] [Related]
18. ADP-ribosylation of highly purified rat brain mitochondria. Masmoudi A; Islam F; Mandel P J Neurochem; 1988 Jul; 51(1):188-93. PubMed ID: 2837535 [TBL] [Abstract][Full Text] [Related]
19. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors. Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889 [TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis. Sims JL; Berger SJ; Berger NA Biochemistry; 1983 Oct; 22(22):5188-94. PubMed ID: 6317018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]